
Drugmakers Pfizer and Moderna have filed applications for emergency use authorisation with the US Food and Drug Administration for a second “booster” dose of their Covid-19 vaccines, which an advisory panel for the federal agency is expected to discuss in April.
Pfizer is seeking approval for a second booster dose for people aged 65 and older, while Modern is seeking authorisation for a second booster for all adults.